NEW YORK (GenomeWeb) – Twist Bioscience today announced that it has secured a loan facility of up to $10 million with Silicon Valley Bank.

The San Francisco-based synthetic DNA manufacturer said that it can draw upon an unspecified portion of the loan immediately, while the remainder of the funds will be available upon the completion of certain milestones.

"This new loan facility provides flexibility within our business model to pursue strategic opportunities while maintaining our focus on product development," Twist Bio CEO Emily Leproust said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.